MNPR vs VNO · $431.4M cap vs rev $921.3M
Monopar Therapeutics Inc (MNPR) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
Monopar Therapeutics Inc (MNPR) is a biotechnology company listed on US.
VNO (VNO) common stock.
Latest reported MNPR revenue for 2026-06-30 was $0. Net income was -$9.2M. MNPR currently screens at market cap $431.4M.
Latest reported VNO revenue for 2026-06-30 was $921.3M. Net income was $24.6M. VNO currently screens at market cap $0.
MNPR currently screens at market cap $431.4M. VNO currently screens at market cap $0.
Not investment advice. Open the MNPR and VNO stock pages for the full models.
Not investment advice.